Cloning and characterization of a novel human histone deacetylase, HDAC8
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs) are a growing family of enzymes implicated in transcriptional regulation by affecting the acetylation state of core histones in the nucleus of cells. HDACs are known to have key roles in the regulation of cell proliferation [Brehm, Miska, McCance, Reid, Bannister and Kouzarides (1998) Nature (London) 391, 597-600], and aberrant recruitment of an HDAC complex has been shown to be a key step in the mechanism of cell transformation in acute promyelocytic leukaemia [Grignani, De Matteis, Nervi, Tomassoni, Gelmetti, Cioce, Fanelli, Ruthardt, Ferrara, Zamir et al. (1998) Nature (London) 391, 815-818; Lin, Nagy, Inoue, Shao, Miller and Evans (1998), Nature (London) 391, 811-814]. Here we present the complete nucleotide sequence of a cDNA clone, termed HDAC8, that encodes a protein product with similarity to the RPD3 class (I) of HDACs. The predicted 377-residue HDAC8 product contains a shorter C-terminal extension relative to other members of its class. After expression in two cell systems, immunopurified HDAC8 is shown to possess trichostatin A- and sodium butyrate-inhibitable HDAC activity on histone H4 peptide substrates as well as on core histones. Expression profiling reveals the expression of HDAC8 to various degrees in every tissue tested and also in several tumour lines. Mutation of two adjacent histidine residues within the predicted active site severely decreases activity, confirming these residues as important for HDAC8 enzyme activity. Finally, linkage analysis after radiation hybrid mapping has localized HDAC8 to chromosomal position Xq21.2-Xq21.3. These results confirm HDAC8 as a new member of the HDAC family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HDAC8 is a 377 residue class I enzyme that lies close to the phylogenetic boundary between the class I and class II HDACs, and maps to the X chromosome (Hu et al., 2000; Buggy et al., 2000; Van den Wyngaert et al., 2000).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Buggy et al., 2000
Experimental — accuracy not yet measuredIn the citing paper
“The HDAC8 protein is localized primarily in the nucleus, where it acts as a transcriptional repressor and shows a rather ubiquitous expression (Buggy et al., 2000;Hu et al., 2000).”
From HDACs and the epigenetic plasticity of cancer cells: target the complexity (2022) · cites this paper as Buggy et al., 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Winer, J., Jung, C. K. S., Shackel, I., & Williams, P. M. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4085 · Cited by 1,387
Gene Splicing by Overlap Extension: Tailor-Made Genes Using the Polymerase Chain Reaction
Horton, R. M., Cai, Z., Ho, S. N., & Pease, L. R. (2013) · BioTechniques · doi:10.2144/000114017 · Cited by 1,289
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,230
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
Rb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 960
Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression
Laherty, C. D., Yang, W.-M., Sun, J.-M., Davie, J. R., Seto, E., & Eisenman, R. N. (1997) · Cell · doi:10.1016/s0092-8674(00)80215-9 · Cited by 938
Cited by
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
Donohoe, D. R., Collins, L. B., Wali, A., Bigler, R., Sun, W., & Bultman, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.033 · Cited by 993
“The concentration of butyrate required to inhibit HDAC activity by 50%, referred to as the IC50, is 100–350 mM (Buggy et al., 2000; Sekhavat et al., 2007).”
BackgroundGao, L., Cueto, M. A., Asselbergs, F., & Atadja, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111871200 · Cited by 744
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
“…the first crystal to the phylogenetic boundary between the class I andstructures of a human HDAC: the structures of human class II HDACs, and maps to the X chromosome (Hu etHDAC8 complexed with four structurally diverse hyal., 2000; Buggy et al., 2000; Van den Wyngaert et al.,droxamate inhibitors.”
BackgroundHistone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
THIAGALINGAM, S., CHENG, K., LEE, H. J., MINEVA, N., THIAGALINGAM, A., & PONTE, J. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05964.x · Cited by 700
The Human Histone Deacetylase Family
Gray, S. G., & Ekström, T. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5080 · Cited by 546
“3 using radiation hybrid mapping [38].”
BackgroundBalasubramanian, S., Ramos, J., Luo, W., Sirisawad, M., Verner, E., & Buggy, J. J. (2008) · Leukemia · doi:10.1038/leu.2008.9 · Cited by 458
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Li, G., Tian, Y., & Zhu, W.-G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576946 · Cited by 352
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
Ramaiah, M. J., Tangutur, A. D., & Manyam, R. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119504 · Cited by 345
Wade, P. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.693 · Cited by 317
Experience-Dependent Epigenetic Modifications in the Central Nervous System
Sweatt, J. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.002 · Cited by 307
“Classical isoforms of HDACs catalyze the removal of acetyl groups from lysine residues through a Zn2+-dependent charge-relay system (18,19).”
A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening
Wegener, D., Wirsching, F., Riester, D., & Schwienhorst, A. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00305-8 · Cited by 282
HDAC8: a multifaceted target for therapeutic interventions
Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284
Class II histone deacetylases: Structure, function, and regulation
Bertos, N. R., Wang, A. H., & Yang, X.-J. (2001) · Biochemistry and Cell Biology · doi:10.1139/bcb-79-3-243 · Cited by 276
Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin
Tóth, K. F., Knoch, T. A., Wachsmuth, M., Frank-Stöhr, M., Stöhr, M., Bacher, C. P., Müller, G., & Rippe, K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01293 · Cited by 260
“The dependence of apoptosis on the concentration of TSA was analyzed by assuming that the percentage of cells in apoptosis (a) goes linear with the fractional saturation (θ) of HDACs with TSA according to Eqn 1.”
BackgroundMethodInfluentialFunctional Domains of Histone Deacetylase-3
Yang, W.-M., Tsai, S.-C., Wen, Y.-D., Fejér, G., & Seto, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105993200 · Cited by 248
Cloning and characterization of a histone deacetylase, HDAC9
Zhou, X., Marks, P. A., Rifkind, R. A., & Richon, V. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191375098 · Cited by 245
Targeting histone deacetylase in cancer therapy
Lin, H., Chen, C., Lin, S., Weng, J., & Chen, C. (2006) · Medicinal Research Reviews · doi:10.1002/med.20056 · Cited by 241
Isoform-specific histone deacetylase inhibitors: The next step?
Balasubramanian, S., Verner, E., & Buggy, J. J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.013 · Cited by 220
HDAC3: taking the SMRT-N-CoRrect road to repression
Karagianni, P., & Wong, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210612 · Cited by 222
“HDAC8 would be later added to this class, which includes mammalian enzymes related to yeast Rpd3 (Buggy et al., 2000).”
From 1957 to Nowadays: A Brief History of Epigenetics
Peixoto, P., Cartron, P.-F., Serandour, A. A., & Hervouet, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207571 · Cited by 215
Kumar, V., Kundu, S., Singh, A., & Singh, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666210609160017 · Cited by 210
“HDAC8 is composed of a large catalytic domain along with NLS at the central region [23, 24].”
BackgroundThe Activity of Antiepileptic Drugs as Histone Deacetylase Inhibitors
Eyal, S., Yagen, B., Sobol, E., Altschuler, Y., Shmuel, M., & Bialer, M. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.00104.x · Cited by 205
Liu, H.-L., Chen, Y., Cui, G.-H., & Zhou, J.-F. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00081.x · Cited by 203
Waltregny, D., Glénisson, W., Tran, S. L., North, B. J., Verdin, E., Colige, A., & Castronovo, V. (2005) · The FASEB Journal · doi:10.1096/fj.04-2303fje · Cited by 197
Rettig, I., Koeneke, E., Trippel, F., Mueller, W. C., Burhenne, J., Kopp-Schneider, A., Fabian, J., Schober, A., Fernekorn, U., von Deimling, A., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.24 · Cited by 180
“family member 8 (HDAC8) together with HDAC1, 2 and 3 compose class I.(4) HDACs remove acetyl groups from lysine”
BackgroundHDAC1 Acetylation Is Linked to Progressive Modulation of Steroid Receptor-Induced Gene Transcription
Qiu, Y., Zhao, Y., Becker, M., John, S., Parekh, B. S., Huang, S., Hendarwanto, A., Martinez, E. D., Chen, Y., Lu, H., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.019 · Cited by 162
Histone Deacetylase 4 Possesses Intrinsic Nuclear Import and Export Signals
Wang, A. H., & Yang, X.-J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5992-6005.2001 · Cited by 183
“Class I HDACs (HDAC1, HDAC2, HDAC3, and HDAC8) show high similarity to the yeast deacetylase Rpd3 (4, 9, 12, 22, 56, 57, 65, 66).”
BackgroundThe emerging role of class II histone deacetylases
Fischle, W., Kiermer, V., Dequiedt, F., & Verdin, E. (2001) · Biochemistry and Cell Biology · doi:10.1139/bcb-79-3-337 · Cited by 181
“All class I HDACs are expressed in most tissues and cell lines (Buggy et al. 2000; Dangond et al. 1998; Emiliani et al. 1998; Hu et al. 2000; Van den Wyngaert et al. 2000; Yang et al. 1997).”
BackgroundTong, J. J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.1114 · Cited by 181
Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response
Kao, G. D., McKenna, W. G., Guenther, M. G., Muschel, R. J., Lazar, M. A., & Yen, T. J. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209065 · Cited by 179
“Class I HDACs (HDAC1, HDAC2, HDAC3, and HDAC8) are similar to the yeast deacetylase Rpd3 (Yang et al., 1996; Dangond et al., 1998; Emiliani et al., 1998; Buggy et al., 2000; Hu et al., 2000).”
BackgroundSuzuki, T., Ota, Y., Ri, M., Bando, M., Gotoh, A., Itoh, Y., Tsumoto, H., Tatum, P. R., Mizukami, T., Nakagawa, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300837y · Cited by 165
Epigenetic regulation of autosomal gene expression by sex chromosomes
Wijchers, P. J., & Festenstein, R. J. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.01.004 · Cited by 164
Sex differences in the late first trimester human placenta transcriptome
Gonzalez, T. L., Sun, T., Koeppel, A. F., Lee, B., Wang, E. T., Farber, C. R., Rich, S. S., Sundheimer, L. W., Buttle, R. A., Chen, Y.-D. I., et al. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0165-y · Cited by 159
Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A
Lee, H., Rezai-Zadeh, N., & Seto, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.765-773.2004 · Cited by 153
“HDAC8 cDNA was identified initially by three independent groups using sequence homology database searches with class I HDAC proteins (6, 20, 40).”
BackgroundMethodGantt, S. L., Gattis, S. G., & Fierke, C. A. (2006) · Biochemistry · doi:10.1021/bi060212u · Cited by 150
Next-generation of selective histone deacetylase inhibitors
Yang, F., Zhao, N., Ge, D., & Chen, Y. (2019) · RSC Advances · doi:10.1039/c9ra02985k · Cited by 157
Tian, Y., Wong, V. W. S., Wong, G. L. H., Yang, W., Sun, H., Shen, J., Tong, J. H. M., Go, M. Y. Y., Cheung, Y. S., Lai, P. B. S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3786 · Cited by 133
“HDAC8 is the least characterized class 1 HDAC originally cloned in 2000 (32-34).”
Waltregny, D., de Leval, L., Glénisson, W., Tran, S. L., North, B. J., Bellahcène, A., Weidle, U. H., Verdin, E. M., & Castronovo, V. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63320-2 · Cited by 147
“We therefore conclude that HDAC8 is a predominantly cytosolic HDAC.”
BackgroundBuggy, J. J., Cao, Z. A., Bass, K. E., Verner, E., Balasubramanian, S., Liu, L., Schultz, B. E., Young, P. R., & Dalrymple, S. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0442 · Cited by 127
“There are 11 known isoforms of the classic HDAC family, denoted HDAC1 to HDAC11 (1, 2).”
BackgroundSelf-citationKurtev, V., Margueron, R., Kroboth, K., Ogris, E., Cavaillès, V., & Seiser, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312300200 · Cited by 120
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
Banerjee, S., Adhikari, N., Amin, S. A., & Jha, T. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.039 · Cited by 108
HDAC11 is a novel drug target in carcinomas
Deubzer, H. E., Schier, M. C., Oehme, I., Lodrini, M., Haendler, B., Sommer, A., & Witt, O. (2013) · International Journal of Cancer · doi:10.1002/ijc.27876 · Cited by 112
“For HDAC8, the mutant H142A/H143A form was shown to have lost more than 80% of its catalytic activity relative to wild-type.(16) For the expression of Myc-tagged HDAC11, both wild-type and mutant forms of HDAC11 were transferred via an LR-reaction into a Gateway-compatible version of pcDNA3.”
Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases
Chakrabarti, A., Melesina, J., Kolbinger, F. R., Oehme, I., Senger, J., Witt, O., Sippl, W., & Jung, M. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0117 · Cited by 111
Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate
Sekhavat, A., Sun, J.-M., & Davie, J. R. (2007) · Biochemistry and Cell Biology · doi:10.1139/o07-145 · Cited by 110
“2A with an IC50 value of 101 mmol/L, similar to published values (Buggy et al. 2000; Emiliani et al. 1998), and in Fig.”
BackgroundResultHomo-oligomerisation and nuclear localisation of mouse histone deacetylase 111Edited by J. Karn
Taplick, J., Kurtev, V., Kroboth, K., Posch, M., Lechner, T., & Seiser, C. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4569 · Cited by 126
Thaler, F., & Mercurio, C. (2014) · ChemMedChem · doi:10.1002/cmdc.201300413 · Cited by 95
Richon, V. M., Zhou, X., Rifkind, R. A., & Marks, P. A. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0376 · Cited by 97
Lee, J.-I., Nian, H., Cooper, A. J. L., Sinha, R., Dai, J., Bisson, W. H., Dashwood, R. H., & Pinto, J. T. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0047 · Cited by 97
Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets
Javaid, N., & Choi, S. (2017) · Genes · doi:10.3390/genes8080196 · Cited by 106
“Class II HDACs are considered to be involved in developmental processes and cellular differentiation due to their specifically restricted expression behavior, unlike those of class I [147,148].”
BackgroundHDAC8 cooperates with SMAD3/4 complex to suppress SIRT7 and promote cell survival and migration
Tang, X., Li, G., Su, F., Cai, Y., Shi, L., Meng, Y., Liu, Z., Sun, J., Wang, M., Qian, M., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa039 · Cited by 91
“HDAC8 is a class I HDAC that deacetylates histone H3 and H4 at nonspecific lysines (22,23).”
Chen, Z., Clark, S., Birkeland, M., Sung, C.-M., Lago, A., Liu, R., Kirkpatrick, R., Johanson, K., Winkler, J. D., & Hu, E. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00322-1 · Cited by 87
Lee, H., Sengupta, N., Villagra, A., Rezai-Zadeh, N., & Seto, E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01971-05 · Cited by 86
“Based on similarity to yeast proteins, human HDACs can be divided into three different groups.”
MethodInfluentialKinetics and Comparative Reactivity of Human Class I and Class IIb Histone Deacetylases
Schultz, B. E., Misialek, S., Wu, J., Tang, J., Conn, M. T., Tahilramani, R., & Wong, L. (2004) · Biochemistry · doi:10.1021/bi0494471 · Cited by 88
An Unbiased Approach To Identify Endogenous Substrates of “Histone” Deacetylase 8
Olson, D. E., Udeshi, N. D., Wolfson, N. A., Pitcairn, C. A., Sullivan, E. D., Jaffe, J. D., Svinkina, T., Natoli, T., Lu, X., Paulk, J., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500492r · Cited by 81
HDAC8 substrates: Histones and beyond
Wolfson, N. A., Pitcairn, C. A., & Fierke, C. A. (2013) · Biopolymers · doi:10.1002/bip.22135 · Cited by 80
Histone deacetylases: Focus on the nervous system
Morrison, B. E., Majdzadeh, N., & D’Mello, S. R. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7035-9 · Cited by 95
Pathological Role of HDAC8: Cancer and Beyond
Kim, J. Y., Cho, H., Yoo, J. H., Kim, G. W., Jeon, Y. H., Lee, S. W., & Kwon, S. H. (2022) · Cells · doi:10.3390/cells11193161 · Cited by 92
“HDAC8 has over 30% amino acid identity with other class I HDACs, including the nine conserved blocks that serve the catalytic function of deacetylase, but have a shorter C-terminal sequence [11,13].”
BackgroundVanaja, G. R., Ramulu, H. G., & Kalle, A. M. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0231-4 · Cited by 74
“HDAC8, the best structurally characterized [4] of all HDACs is known to be the first human HDAC to be crystallized with bound inhibitors [5–8].”
BackgroundDing, Z., Gillespie, L. L., & Paterno, G. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.250-258.2003 · Cited by 77
“Eleven human HDACs have been identified (7, 10, 11, 13, 17, 19, 34, 42) and have been divided into three classes based on their homology to Saccharomyces cerevisiae proteins (5, 8, 9, 12, 28, 31, 36), and it is believed that the different HDACs may have unique temporal and spatial expression patterns that con-”
BackgroundTargeting of HDAC8 and investigational inhibitors in neuroblastoma
Oehme, I., Deubzer, H. E., Lodrini, M., Milde, T., & Witt, O. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/14728220903241658 · Cited by 75
“HDAC8 was cloned and identified in the year 2000 by searching an EST database for sequences similar to HDAC1, HDAC2 and HDAC3, followed by 5-prime and 3-prime RACE (Rapid Amplification of cDNA Ends) [65-67].”
BackgroundMethodBasile, V., Mantovani, R., & Imbriano, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507712200 · Cited by 91
Evolution of the arginase fold and functional diversity
Dowling, D. P., Di Costanzo, L., Gennadios, H. A., & Christianson, D. W. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7554-z · Cited by 74
Waltregny, D., North, B. J., Mellaert, F. V., de Leval, J., Verdin, E. M., & CASTRONOVO, V. (2004) · PubMed · doi:10.4081/897 · Cited by 77
Amin, S. A., Adhikari, N., & Jha, T. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.002 · Cited by 74
Targeting Histone Deacetylases: A Novel Approach in Parkinson’s Disease
Sharma, S., & Taliyan, R. (2015) · Parkinson's Disease · doi:10.1155/2015/303294 · Cited by 70
Scott, K. L., & Plon, S. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4522-4531.2003 · Cited by 73
“Yeast Rpd3 most closely resembles enzymes in the human class I HDAC category, including HDAC1, HDAC2, HDAC3, and HDAC8 ( 5 , 9, 17, 46).”
BackgroundAzetidinones as Zinc‐Binding Groups to Design Selective HDAC8 Inhibitors
Galletti, P., Quintavalla, A., Ventrici, C., Giannini, G., Cabri, W., Penco, S., Gallo, G., Vincenti, S., & Giacomini, D. (2009) · ChemMedChem · doi:10.1002/cmdc.200900309 · Cited by 61
Pinto, J. T., Lee, J.-I., Sinha, R., MacEwan, M. E., & Cooper, A. J. L. (2010) · Amino Acids · doi:10.1007/s00726-010-0578-3 · Cited by 65
“Eleven of the eighteen recognized HDACs harbor a coordinating zinc atom within their active site (Buggy et al. 2000; Vanommeslaeghe et al. 2005).”
BackgroundLopez, G., Bill, K. L. J., Bid, H. K., Braggio, D., Constantino, D., Prudner, B., Zewdu, A., Batte, K., Lev, D., & Pollock, R. E. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133302 · Cited by 60
“Hyperacetylation of core histone proteins yields conflicting results: HDAC8 can deacetylate histone 3 and 4 in some, but not all cell types [4], [5].”
BackgroundPapeleu, P., Vanhaecke, T., Elaut, G., Vinken, M., Henkens, T., Snykers, S., & Rogiers, V. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590935639 · Cited by 64
Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)
Chotitumnavee, J., Yamashita, Y., Takahashi, Y., Takada, Y., Iida, T., Oba, M., Itoh, Y., & Suzuki, T. (2022) · Chemical Communications · doi:10.1039/d2cc00272h · Cited by 59
Higuchi, T., Nakayama, T., Arao, T., Nishio, K., & Yoshie, O. (2013) · Blood · doi:10.1182/blood-2012-07-441022 · Cited by 56
HDACs and the epigenetic plasticity of cancer cells: target the complexity
Brancolini, C., Gagliano, T., & Minisini, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108190 · Cited by 55
Acetylation of Heat Shock Protein 20 (Hsp20) Regulates Human Myometrial Activity
Karolczak-Bayatti, M., Sweeney, M., Cheng, J., Edey, L., Robson, S. C., Ulrich, S. M., Treumann, A., Taggart, M. J., & Europe-Finner, G. N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278549 · Cited by 55
NMR Profiling of Histone Deacetylase and Acetyl-transferase Activities in Real Time
Dose, A., Liokatis, S., Theillet, F., Selenko, P., & Schwarzer, D. (2011) · ACS Chemical Biology · doi:10.1021/cb1003866 · Cited by 56
Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6
Wood, M., Rymarchyk, S., Zheng, S. G., & Cen, Y. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.12.009 · Cited by 65
Ganai, S. A. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.130 · Cited by 53
Park, J.-Y., & Juhnn, Y. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.152 · Cited by 57
HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia
Spreafico, M., Gruszka, A., Valli, D., Mazzola, M., Deflorian, G., Quintè, A., Totaro, M. G., Battaglia, C., Alcalay, M., Marozzi, A., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00844 · Cited by 54
Eyal, S., Yagen, B., Shimshoni, J. A., & Bialer, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.012 · Cited by 53
Xu, Y., Sengupta, P. K., Seto, E., & Smith, B. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511724200 · Cited by 54
A Bioluminogenic HDAC Activity Assay: Validation and Screening
Halley, F., Reinshagen, J., Ellinger, B., Wolf, M., Niles, A. L., Evans, N. J., Kirkland, T. A., Wagner, J. M., Jung, M., Gribbon, P. M., et al. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111416004 · Cited by 51
Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer
Hsieh, C.-L., Ma, H.-P., Su, C.-M., Chang, Y.-J., Hung, W.-Y., Ho, Y.-S., Huang, W.-J., & Lin, R.-K. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.092 · Cited by 47
Thangapandian, S., John, S., Lee, Y., Kim, S., & Lee, K. W. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129440 · Cited by 52
“Some structural studies predicted that both histidine residues forming two independent hydrogen bonds are essential for the charge relay systems present in the active site [1,36].”
BackgroundDoherty, R., O’Farrelly, C., & Meade, K. G. (2013) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2013.05.004 · Cited by 54
Amin, S. A., Adhikari, N., & Jha, T. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0130 · Cited by 45
Wang, Y. F., Liu, F., Sherwin, S. K., Farrelly, M. L., Yan, X. G., Croft, A. J., Liu, T., Jin, L., Zhang, X. D., & Jiang, C. C. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.11.009 · Cited by 42
Ren, G., Zhang, G., Dong, Z., Liu, Z., Li, L., Feng, Y., Su, D., Zhang, Y., Huang, B., & Lü, J. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.015 · Cited by 46
Kuzmochka, C., Abdou, H. S., Haché, R. J. G., & Atlas, E. (2014) · Endocrinology · doi:10.1210/en.2014-1565 · Cited by 43
Pramanik, S. D., Halder, A. K., Mukherjee, U., Kumar, D., Dey, Y. N., & Mogana, R. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.948217 · Cited by 47
“They are the most common type of HDACs found in the nucleus, and they are related to the yeast Rpd3 in several ways (Emiliani et al., 1998; Buggy et al., 2000; Hu et al., 2000).”
BackgroundCastañeda, C. A., Wolfson, N. A., Leng, K. R., Kuo, Y.-M., Andrews, A. J., & Fierke, C. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811026 · Cited by 38
“However, outside of qualitative experiments (17, 18), there has been no kinetic characterization of HDAC-catalyzed deacetylation of protein substrates.”
BackgroundExpression of class I histone deacetylases during chick and mouse development
Murko, C., Lagger, S., Steiner, M., Seiser, C., Schöfer, C., & Pusch, O. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.092971cm · Cited by 48
“In contrast to the original papers, documenting Hdac8 mRNA expression in multiple human organs (Buggy et al., 2000; Hu et al., 2000; Van den Wyngaert et al., 2000) a recent study indicated that in normal human tissues Hdac8 is exclusively expressed in cells showing smooth muscle differentiation.”
ResultAn Overview of the Molecular Basis of Epigenetics
Sweatt, J. D., Nestler, E. J., Meaney, M. J., & Akbarian, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391494-1.00001-x · Cited by 49
Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
Lehmann, M., Hoffmann, M. J., Koch, A., Ulrich, S. M., Schulz, W. A., & Niegisch, G. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0059-8 · Cited by 34
“It is a protein of 377 amino acids and contains a NLS in the center of the catalytic domain [27-29].”
BackgroundKelly, J. M., Taylor, M. C., Horn, D., Loža, E., Kalvinsh, I., & Björkling, F. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.072 · Cited by 36
Ha, S.-D., Han, C. Y., Reid, C., & Kim, S. O. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400420 · Cited by 36
“HDAC8 was shown to deacetylate the core histones H2A/H2B, H3, and H4 in vitro (43, 44); however, its activities toward specific histones in vivo are unknown.”
BackgroundShen, J., Najafi, S., Stäble, S., Fabian, J., Koeneke, E., Kolbinger, F. R., Wrobel, J. K., Meder, B., Distel, M., Heimburg, T., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0080-0 · Cited by 31
“HDAC family member 8 (HDAC8) together with HDACs 1, 2, and 3 comprise class I [7].”
BackgroundOmonijo, O., Wongprayoon, P., Ladenheim, B., McCoy, M. T., Govitrapong, P., Jayanthi, S., & Cadet, J. L. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.10.008 · Cited by 31
“The cloning and characterization of HDAC8 was first published by several investigators in 2000 and was shown to share homologies with other known Class I HDACs (Buggy et al, 2000; Hu et al, 2000).”
Background
Metadata
- Authors
- BUGGY, J. J., SIDERIS, M. L., MAK, P., LORIMER, D. D., MCINTOSH, B., & CLARK, J. M.
- Affiliations
- AXYS Pharmaceuticals, 180 Kimball Way, South San Francisco, CA 94080, U.S.A.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-08-09
- Volume
- 350
- Issue
- 1
- Pages
- 199-205
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221242
- OpenAlex
- W1977831138
- Cited by
- 197
- References
- 44
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 6 · 2023: 4 · 2022: 10 · 2021: 4 · 2020: 9 · 2019: 5 · 2018: 8 · 2017: 14 · 2016: 9 · 2015: 9 · 2014: 9 · 2013: 9 · 2012: 10
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- HDAC8, histone deacetylase, histone H4 deacetylation, tissue expression profiling, cDNA cloning, transcriptional regulation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Chromosome Mapping, HeLa Cells, Histone Deacetylases, Humans, Molecular Sequence Data, Repressor Proteins, X Chromosome, Sequence Homology, Amino Acid, DNA, Complementary, Spodoptera
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.